Aquamarine Financial (Cayman) Ltd
About Aquamarine Financial (Cayman) Ltd’s 13F portfolio
Aquamarine Financial (Cayman) Ltd is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Aquamarine Financial (Cayman) Ltd reported $1.8B across 17 US-listed positions (). Its largest position is BANCO BRADESCO S A (BBD) at 36% of the reported book, and its ten biggest holdings make up 99% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NYSE: BBD BANCO BRADESCO S A | $2.30 −3.77% | 36% | 186.9M | $649.0M |
| 2 | NYSE: YPF YPF SOCIEDAD ANONIMA | $33.28 −5.19% | 31% | 12.4M | $565.9M |
| 3 | NASDAQ: GGAL GRUPO FINANCIERO GALICIA S.A | $26.07 −6.16% | 9.7% | 3.5M | $175.9M |
| 4 | NYSE: NU NU HLDGS LTD | $11.82 −2.15% | 6.6% | 9.0M | $119.9M |
| 5 | NYSE: BMA BANCO MACRO S A | $51.52 −4.43% | 4.3% | 842K | $78.0M |
| 6 | NYSE: GGB GERDAU SA | $4.34 0.00% | 3.7% | 16.7M | $67.6M |
| 7 | NYSE: BSBR BANCO SANTANDER BRASIL S A | $4.72 −2.07% | 3.0% | 10.4M | $54.6M |
| 8 | NYSE: BBAR BANCO BBVA ARGENTINA S A | $9.14 −6.35% | 1.8% | 1.7M | $33.4M |
| 9 | NASDAQ: PGY PAGAYA TECHNOLOGIES LTD | $14.62 −6.10% | 1.8% | 1.8M | $32.3M |
| 10 | NASDAQ: ORMP ORAMED PHARMACEUTICALS INC | $3.69 −5.14% | 0.7% | 2.5M | $12.1M |
| 11 | NASDAQ: DRTS ALPHA TAU MEDICAL LTD | $11.31 −5.83% | 0.5% | 722K | $9.1M |
| 12 | NYSE: CSAN COSAN S A | $3.13 −3.69% | 0.3% | 2.1M | $6.0M |
| 13 | NASDAQ: INVZ INNOVIZ TECHNOLOGIES LTD | $0.11 −22.46% | 0.2% | 5.8M | $4.4M |
| 14 | NASDAQ: PLSM PULSENMORE LTD | — — | 0.1% | 339K | $2.0M |
| 15 | NYSE: TGS TRANSPORTADORA DE GAS DEL SU | $19.95 −1.58% | 0.0% | 30K | $883K |
| 16 | NYSE: CEPU CENTRAL PUERTO S A | $10.10 −3.53% | 0.0% | 19K | $287K |
| 17 | — VALENS SEMICONDUCTOR LTD | — — | 0.0% | 560K | $16K |
Showing the 17 largest positions reported in this 13F.
- Financial Services61%
- Energy32%
- Basic Materials3.7%
- Technology1.8%
- Healthcare1.2%
- Consumer Cyclical0.2%
- Utilities0.0%
- AddedBBDBANCO BRADESCO S A+19.2%$649.0M
- AddedYPFYPF SOCIEDAD ANONIMA+37.9%$565.9M
- AddedGGALGRUPO FINANCIERO GALICIA S.A+48.9%$175.9M
- AddedNUNU HLDGS LTD+798%$119.9M
- AddedBMABANCO MACRO S A+58.2%$78.0M
- AddedBSBRBANCO SANTANDER BRASIL S A+5.9%$54.6M
- AddedBBARBANCO BBVA ARGENTINA S A+37.7%$33.4M
- NewPGYPAGAYA TECHNOLOGIES LTD—$32.3M
- AddedORMPORAMED PHARMACEUTICALS INC+18.9%$12.1M
- AddedINVZINNOVIZ TECHNOLOGIES LTD+12.6%$4.4M
- SoldSCOPROSHARES TR II−100%—
Reading Aquamarine Financial (Cayman) Ltd’s 13F portfolio
Aquamarine Financial (Cayman) Ltd’s $1.8B 13F book is spread across 17 reported positions and is highly concentrated — its ten largest positions alone are 99% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are BBD, YPF, GGAL, NU and BMA, led by BANCO BRADESCO S A (BBD) at 36% of the portfolio. The heaviest sector exposure is Financial Services (61%), then Energy (32%).
What Aquamarine Financial (Cayman) Ltd changed last quarter
Between 2026-03-31 and Q2 2026, Aquamarine Financial (Cayman) Ltd was a net buyer: it opened 1 new positions and added to 9 more, while trimming 0 and closing 1 outright. Against a 17-name book, that is moderate turnover, pointing to steady rotation within the portfolio. Its largest new or increased position was BANCO BRADESCO S A (BBD), and its biggest reduction was PROSHARES TR II (SCO).
What a 13F does and doesn’t reveal
A 13F captures only Aquamarine Financial (Cayman) Ltd’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Aquamarine Financial (Cayman) Ltd is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Aquamarine Financial (Cayman) Ltd's profile on this page is built directly from those filings.
How current is the 13F data on Aquamarine Financial (Cayman) Ltd's page?
It reflects Aquamarine Financial (Cayman) Ltd's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Aquamarine Financial (Cayman) Ltd files its next quarterly report, this page refreshes automatically.
Can I see Aquamarine Financial (Cayman) Ltd's complete list of holdings?
This page highlights Aquamarine Financial (Cayman) Ltd's largest positions rather than all 17 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Aquamarine Financial (Cayman) Ltd's filings.
Does a 13F show everything Aquamarine Financial (Cayman) Ltd owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Aquamarine Financial (Cayman) Ltd's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Aquamarine Financial (Cayman) Ltd made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

